Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Frisullo

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
European Stroke Journal|April 23, 2025
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT studyMatteo Foschi, Federico De Santis, Lucio D'Anna, et al.
European Stroke Journal|January 30, 2026
Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and updateHanne Christensen, Francesca Romana Pezzella, Melinda Berg Roaldsen, et al.
Stroke|December 9, 2024
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Lucio D'Anna, Eleonora De Matteis, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
Journal of the Neurological Sciences|August 7, 2025
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT studyFederico De Santis, Matteo Foschi, Michele Romoli, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
European Stroke Journal|April 23, 2025
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT studyMatteo Foschi, Federico De Santis, Lucio D'Anna, et al.
European Stroke Journal|January 30, 2026
Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and updateHanne Christensen, Francesca Romana Pezzella, Melinda Berg Roaldsen, et al.
Stroke|December 9, 2024
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Lucio D'Anna, Eleonora De Matteis, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
Journal of the Neurological Sciences|August 7, 2025
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT studyFederico De Santis, Matteo Foschi, Michele Romoli, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
Pageof 16